F8 and hemophilia: In the last decades, thanks to the availability of recombinant FVIII (rFVIII) concentrates characterized by high safety and efficacy, and the spread of continuous treatment regimens aimed at prevention of bleeds (prophylaxis), there has been a continuous improvement in the treatment of patients with haemophilia.